Download PDF
Thromb Haemost 1995; 74(04): 1175-1179
DOI: 10.1055/s-0038-1649899
Original Article
Vessel Wall
Schattauer GmbH Stuttgart

Oxidized LDL and Reduction of the Antiaggregating Activity of Nitric Oxide Derived from Endothelial Cells

P Minuz
1   The Institutes of Clinica Medica, Policilnico Borgo Roma, University of Verona, Verona, Italy
,
C Lechi
2   The Institutes of Chimica e Microscopla Clinica, Policilnico Borgo Roma, University of Verona, Verona, Italy
,
S Gaino
2   The Institutes of Chimica e Microscopla Clinica, Policilnico Borgo Roma, University of Verona, Verona, Italy
,
S Bonapace
1   The Institutes of Clinica Medica, Policilnico Borgo Roma, University of Verona, Verona, Italy
,
L Fontana
1   The Institutes of Clinica Medica, Policilnico Borgo Roma, University of Verona, Verona, Italy
,
U Garbin
3   The Institutes of Semeiotica e Nefrologia Medica, Policilnico Borgo Roma, University of Verona, Verona, Italy
,
F Paluani
1   The Institutes of Clinica Medica, Policilnico Borgo Roma, University of Verona, Verona, Italy
,
L Cominacini
3   The Institutes of Semeiotica e Nefrologia Medica, Policilnico Borgo Roma, University of Verona, Verona, Italy
,
M Zatti
2   The Institutes of Chimica e Microscopla Clinica, Policilnico Borgo Roma, University of Verona, Verona, Italy
,
A Lechi
1   The Institutes of Clinica Medica, Policilnico Borgo Roma, University of Verona, Verona, Italy
› Author Affiliations
Further Information

Publication History

Received 28 March 1995

Accepted after revision 22 June 1995

Publication Date:
09 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Oxidized LDL has been observed to induce abnormalities in endothelial function which may be relevant for the progression of atherosclerotic lesions. We studied in vitro the possible effects of oxidized LDL on the antiaggregating activity of endothelial cells, which is dependent on release of prostacyclin and nitric oxide. We used an experimental model in which cultured human endothelial cells were placed in the aggregometer in contact with human platelets, after blockade of cyclo-oxygenase by adding acetylsalicylic acid. In this way the antiaggregant effect of endothelial cells was dependent on the release of nitric oxide alone; prevention of antiaggregant activity by preincubation of endothelial cells with 300 μM L-NG-mono-methyl-arginine confirmed this. When this system was used, endothelial cells (2–7.5 X 105ml) almost completely inhibited thrombin-induced (0.02–0.08 U/ml) platelet aggregation (2 × 108 platelets/ml), measured according to Born (11.1% ±8.5 vs 68.6% ±12.6, M ± SD). This antiaggregating activity was reduced when slightly oxidized LDL 100 μg/ml (35.2% ± 14.9, p <0.001), but not native LDL 100 μg/ml (7.5% ± 7.6), was added immediately before aggregation was induced.. Incubation of endothelial cells with oxidized LDL 100 μg/ml for 1 h did not affect the antiaggregating capacity, unless oxidized LDL was present during aggregation (18.3% ± 10.2 vs 35.8% ± 9.6, p <0.02). No significant direct effect of either oxidized or native LDL on stimulated platelet aggregation was observed. Our results indicate that slightly oxidized LDL can reduce the antiaggregating properties of the endothelium, probably by interaction with NO rather than through inhibition of its synthesis.

 

  • References

  • 1 Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809
    CrossrefPubMedGoogle Scholar
  • 2 Ware JA, Heistad DD. Platelet-endothelium interactions. N Engl J Med 1993; 328: 628-635
    CrossrefPubMedGoogle Scholar
  • 3 Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-795
    CrossrefPubMedGoogle Scholar
  • 4 Noll G, Lüscher TF. Influence of lipoproteins on endothelial function. Thromb Res 1994; 74 suppl (Suppl. 01) S45-S54
    CrossrefPubMedGoogle Scholar
  • 5 Radomski MW, Palmer RM J, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmac 1987; 92: 181-187
    CrossrefPubMedGoogle Scholar
  • 6 Hodis HN, Kramsch DM, Avogaro P, Bittolo-Bon G, Cazzolato G, Hwang J, Peterson H, Sevanian A. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-). J Lipid Res 1994; 35: 669-677
    PubMedGoogle Scholar
  • 7 Durante W, Kroll MH, Vanhoutte PM, Schafer AI. Endothelium-Derived Relaxing Factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C. Blood 1992; 79: 110-116
    PubMedGoogle Scholar
  • 8 Hallam TJ, Thompson NT, Scrutton MC, Rink TJ. The role of cytoplasmic free calcium in (he responses of quin-2 loaded human platelets to vasopressin. Biochem J 1994; 221: 897-901
    PubMedGoogle Scholar
  • 9 Born JV R. Quantitative investigation into the aggregation of blood platelets. J Physiol 1962; 162: 67-71
    PubMedGoogle Scholar
  • 10 Smith CW, Marlin D, Rothlein R, Toman C, Anderson DC. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest 1989; 83: 2008-2017
    CrossrefPubMedGoogle Scholar
  • 11 Havel RJ, Eder MA, Bragdon JM. The distribution and chemical composition of ultracenlrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345-1353
    CrossrefPubMedGoogle Scholar
  • 12 Sehuh J, Fairclough GF, Haschemeyer RM. Oxygen-mediated hetcrogenity of apo-low-dcnsity lipoprotein. Proc Natl Acad Sci USA 1978; 75: 3173-3177
    CrossrefPubMedGoogle Scholar
  • 13 Teng JL, Smith LL. High performance liquid chromatography of linoleic hydroperoxides and their corresponding alcohol derivatives. J Chromatogr 1985; 350: 445-451
    CrossrefPubMedGoogle Scholar
  • 14 Mollace V, Salvemini D, Sessa DC, Vane JR. Inhibition of human platelet aggregation by endothelium-derived relaxing factor, sodium nitroprusside or iloprost is potentiated by captopril and reduced thiols. J Pharmacol Exp Ther 1991; 258: 220-223
    PubMedGoogle Scholar
  • 15 Brockman MJ, Eiroa AM, Marcus AJ. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: blockade of aggregation and secretion by an aspirin-insensitive mechanism. Blood 1991; 78: 1033-1040
    PubMedGoogle Scholar
  • 16 Palmer RM J, Moncada S. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem Biophys Res Commun 1989; 158: 348-352
    CrossrefPubMedGoogle Scholar
  • 17 Hassal DG, Owen JS, Bruckdorfer KF. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin. Biochem J 1983; 216: 43
    CrossrefPubMedGoogle Scholar
  • 18 Bühler FR, Tkachuk VA, Hahn AW A, Resink TJ. Low- and high-density lipoproteins as hormonal regulators of platelet, vascular endothelial and smooth muscle cell interactions: relevance to hypertension. J Hypertension 1991; 9: S28-S36
    PubMedGoogle Scholar
  • 19 Naseem KM, Goodall AH, Bruckdorfer KR. The effects of native and oxidised low density lipoproteins on platelet activation. Biochem Soc Trans 1993; 21 (02) S140
    CrossrefPubMedGoogle Scholar
  • 20 Andrews HE, Aitken JW, Hassal DG, Skinner VO, Bruckdorfer KR. Intracellular mechanism in the activation of human platelets by low density lipoprotein. Biochem J 1987; 242: 559-564
    CrossrefPubMedGoogle Scholar
  • 21 Ardlie NG, Selley ML, Simons LA. Platelet activation by oxidatively modified low density lipoproteins. Atherosclerosis 1989; 76: 117-124
    CrossrefPubMedGoogle Scholar
  • 22 Esterbauer H, Jurgens G, Quehnberger O, Koller E. Autoxidation of human low density lipoprotein: loss of polyunsatured fatty acids and vitamin E and generation of aldehydes. J Lipid Res 1987; 28: 495-509
    PubMedGoogle Scholar
  • 23 Plane F, Kerr P, Bruckdorfer KR, Jacobs M. Inhibition of endothelium-dependent relaxation by oxidized low density lipoproteins. Biochem Soc Trans 1990; 18: 1177-1178
    CrossrefPubMedGoogle Scholar
  • 24 Tanner FC, Noll G, Boulanger CM, Lüscher TF. Oxidized Low Density lipoproteins inhibit relaxations of porcine coronary arteries. Circulation 1991; 83: 2012-2020
    CrossrefPubMedGoogle Scholar
  • 25 Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990; 66: 18-27
    PubMedGoogle Scholar
  • 26 Liao JK. Inhibition of Giproteins by low density lipoprotein attenuates bradykinin-stimulated release of endothelial-derived nitric oxide. J Biol Chem 1994; 269: 12987-12992
    PubMedGoogle Scholar
  • 27 Chin JH, Azhar S, Hoffman BB. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest 1992; 89: 10-18
    CrossrefPubMedGoogle Scholar